ResMed

2022Q32023Q32024Q3

	Ebitda	változás		Dátum
Ansell	USD 175.2M		60.8M	2024-06
AtriCure	USD -9697000		7.22M	2024-12
Baxter International	USD 576M		116M	2024-12
Cochlear	AUD 298.9M		18.7M	2024-06
Cooper Companies	USD 243.8M		45.6M	2025-01
CSL	USD 1.71B		1.34B	2024-06
Dexcom	USD 305.3M		98M	2024-12
Edwards Lifesciences	USD 396M		32.4M	2024-12
Fisher Paykel Healthcare	NZD 275.7M		6.4M	2024-09
Globus Medical	USD 145.33M		29.19M	2024-12
Haemonetics	USD 101.88M		6.15M	2024-12
Hologic	USD 326.4M		15.5M	2024-12
Idexx Laboratories	USD 295.64M		42.38M	2024-12
Insulet	USD 130.8M		21.4M	2024-12
Integra LifeSciences	USD 104.98M		43.09M	2024-12
Intuitive Surgical	USD 749.5M		56M	2024-12
Masimo	USD -25600000		79.7M	2024-12
Medtronic	USD 2.44B		134M	2025-01
Philips	EUR 945M		594M	2024-12
Ramsay Health Care	AUD 1.02B		22.3M	2024-12
ResMed	USD 473.14M		26.86M	2024-12
Sigma Healthcare	AUD 19.96M		5.15M	2024-07
Sonic Healthcare	AUD 839.07M		51.09M	2024-12
Steris	USD 319.96M		21.8M	2024-12
Teleflex	USD 212.6M		224K	2024-12
Thermo Fisher Scientific	USD 2.99B		363M	2024-12

ResMed - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.